These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9639747)

  • 1. [The risks and benefits of hormone replacement therapy in postmenopausal women].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):515-6. PubMed ID: 9639747
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 9. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighing the risks and benefits of hormone therapy.
    Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E
    JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy for the prevention of chronic conditions in postmenopausal women.
    Guirguis-Blake J
    Am Fam Physician; 2005 Dec; 72(12):2520-2. PubMed ID: 16370410
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?].
    Mathelin C; Brettes JP
    Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.